drugset / Trial / NCT01578304
Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate the efficacy and safety after 12 weeks oral administration of Imidafenacin 0.1mg b.i.d versus Fesoterodine 4mg once daily for the urge incontinence and/or increased urinary frequency associated with urgency as may occur in patients with overactive bladder.
Timeline
- Start
- 2010-12
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fesoterodine | Other / unclassified | 4 mg | — |
| Subject | Imidafenacin | Small molecule | 0.1 mg | Oral |